<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD005517-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD005517-sec-0015"></div> <div class="table" id="CD005517-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">MTA versus IRM for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="" valign="" colspan="7" rowspan="1" class="table-header"> <p><b> MTA versus IRM for retrograde filling in root canal therapy</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy<br><b>Settings:</b> UK and the Netherlands<br><b>Intervention:</b> MTA versus IRM </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>IRM</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>MTA</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate ‐ 1‐year outcome (teeth as unit of analysis)</b> <br> Assessed by combination of clinical and radiological methods<br> Follow‐up: mean 1 year </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>806 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>879 per 1000</b> <br> (782 to 983) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.09</b> <br> (0.97 to 1.22) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>222<br> (2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br><b>low</b><sup>1</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Weak evidence of little or no difference between MTA and IRM at the first year of follow‐up </p> <p>Insufficient evidence of a difference between MTA and IRM after 2 years of follow‐up (RR 1.06; 95% CI 0.89 to 1.25; participants = 86; studies = 1; quality of evidence: very low<sup>2</sup>) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><b>CI:</b> confidence interval; <b>IRM:</b> intermediate restorative material; <b>MTA:</b> mineral trioxide aggregate; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> we are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by 2 due to (1) high risk of bias: both studies had the personnel unblinded due to the nature of the study design, and <a href="./references#CD005517-bbs2-0001">Chong 2003</a> had incomplete outcome data reported; and (2) imprecision: only 2 studies were included.<br><sup>2</sup> Downgraded by 4 due to (1) risk of bias (downgraded by 1): the only study included had high risk of bias on incomplete data reporting and personnel blinding; (2) imprecision (downgraded by 2): only 1 study included; and (3) indirectness (downgraded by 1): participants were from the UK and therefore the results may not be applicable elsewhere. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD005517-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span> <span class="table-title">MTA versus Super‐EBA for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="" valign="" colspan="7" rowspan="1" class="table-header"> <p><b> MTA versus Super‐EBA for retrograde filling in root canal therapy</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy<br><b>Settings:</b> South Korea<br><b>Intervention:</b> MTA versus Super‐EBA </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Super‐EBA</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> MTA</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate ‐ 1‐year outcome (participants as unit of analysis)</b> <br> Assessed by combination of clinical and radiological methods<br> Follow‐up: mean 1 year </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>931 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>959 per 1000</b> <br> (894 to 1000) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.03</b> <br> (0.96 to 1.10) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>192<br> (1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Insufficient evidence of a difference between MTA and Super‐EBA on retrograde filling after 1‐year follow‐up </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><b>CI:</b> confidence interval; <b>MTA:</b> mineral trioxide aggregate; <b>RR:</b> risk ratio; <b>Super‐EBA:</b> super ethoxybenzoid acid </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> we are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by 4 due to (1) high risk of bias (downgraded by 1): the only included study (<a href="./references#CD005517-bbs2-0005">Song 2012</a>) had high risk of bias regarding incomplete data reporting and personnel blinding; (2) indirectness (downgraded by 1): participants were from South Korea and therefore the results may not be applicable elsewhere; and (3) imprecision (downgraded by 2): only 1 study included and the small population might cause serious imprecision. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD005517-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span> <span class="table-title">Super‐EBA versus IRM for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="" valign="" colspan="7" rowspan="1" class="table-header"> <p><b> Super‐EBA versus IRM for retrograde filling in root canal therapy</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy<br><b>Settings:</b> Sweden<br><b>Intervention:</b> Super‐EBA versus IRM </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>IRM</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Super‐EBA</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate ‐ 1‐year outcome (teeth as unit of analysis)</b> <br> Assessed by combination of clinical and radiological methods<br> Follow‐up: mean 1 year </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>906 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>815 per 1000</b> <br> (725 to 915) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.90</b> <br> (0.80 to 1.01) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>194<br> (1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A very low grade of evidence showed that there might be some possibility that the usage of IRM might slightly increase success rate for retrograde filling compared to Super‐EBA </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><b>CI:</b> confidence interval; <b>IRM:</b> intermediate restorative material; <b>RR:</b> risk ratio; <b>Super‐EBA:</b> super ethoxybenzoid acid </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> we are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by 4 due to (1) high risk of bias (downgraded by 1): high risk of bias existed in the only included study (<a href="./references#CD005517-bbs2-0006">Wälivaara 2011</a>) on allocation concealment and personnel blinding; (2) indirectness (downgraded by 1): participants were from Sweden and therefore the results may not be applicable elsewhere; and (3) imprecision (downgraded by 2): only 1 study included and the small population might cause serious imprecision. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD005517-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span> <span class="table-title">Dentine‐bonded resin composite versus glass ionomer cement for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="" valign="" colspan="7" rowspan="1" class="table-header"> <p><b> Dentine‐bonded resin composite versus glass ionomer cement for retrograde filling in root canal therapy</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy<br><b>Settings:</b> Denmark<br><b>Intervention:</b> dentine‐bonded resin composite versus glass ionomer cement </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Glass ionomer cement</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Dentine‐bonded resin composite</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate ‐ 1‐year outcome PP analysis (participants as unit of analysis)</b> <br> Assessed by combination of clinical and radiological methods<br> Follow‐up: mean 1 year </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>306 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>731 per 1000</b> <br> (490 to 1000) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 2.39</b> <br> (1.60 to 3.59) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>122<br> (1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There was insufficient and weak evidence showing that the usage of dentine‐bonded composite might result in higher success rate assessed by clinical and radiological methods compared to glass ionomer cement </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate ‐ 1‐year outcome PP analysis (root as unit of analysis)</b> <br> Assessed by combination of clinical and radiological methods<br> Follow‐up: mean 1 year </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>519 per 1000</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>825 per 1000</b> <br> (623 to 1000) </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.59</b> <br> (1.20 to 2.09) </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>127<br> (1 study) </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There was insufficient and weak evidence showing that the usage of dentine‐bonded composite might result in higher success rate assessed by radiological methods compared to glass ionomer cement </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><b>CI:</b> confidence interval; <b>PP:</b> per‐protocol; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> we are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by 4 because of (1) high risk of bias (downgraded by 1): the included study (<a href="./references#CD005517-bbs2-0002">Jensen 2002</a>) did not have participants, personnel or outcome assessors blinded; (2) indirectness (downgraded by 1): participants were from Denmark and therefore the results may not be applicable elsewhere; and (3) imprecision (downgraded by 2): only 1 study included and the small population might cause serious imprecision. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD005517-tbl-0005"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 5.</span> <span class="table-title">Glass ionomer cement versus amalgam for retrograde filling in root canal therapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="" valign="" colspan="7" rowspan="1" class="table-header"> <p><b> Glass ionomer cement versus amalgam for retrograde filling in root canal therapy</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients needing retrograde filling in root canal therapy<br><b>Settings:</b> Sweden<br><b>Intervention:</b> glass ionomer cement versus amalgam </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Amalgam</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Glass ionomer cement</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Success rate ‐ 5‐year outcome</b> <br> Clinical and radiological methods<br> Follow‐up: mean 5 years </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>854 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>854 per 1000</b> <br> (717 to 1000) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.00</b> <br> (0.84 to 1.20) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>82<br> (1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>1</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There was insufficient evidence of a difference between glass ionomer cement and amalgam on success rate of retrograde filling during 5 years of follow‐up </p> <p>There was also insufficient evidence of a difference between glass ionomer cement and amalgam on success rate of retrograde filling during 1 year of follow‐up (RR 0.98; 95% CI 0.86 to 1.12; tooth = 105; studies = 1; quality of evidence: very low) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> we are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by 4 due to (1) high risk of bias (downgraded by 1): the included study (<a href="./references#CD005517-bbs2-0003">Jesslen 1995</a>) was at high risk of bias as the personnel were impossible to be blinded considering the nature of the study; (2) indirectness (downgraded by 1): participants were from Sweden and therefore the results may not be applicable elsewhere; and (3) imprecision (downgraded by 2): only 1 study included and the small population might cause serious imprecision. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
